The Influence of Systemic Inflammation Response Index on Survival Outcomes of Limited-Stage Small-Cell Lung Cancer Patients Treated with Concurrent Chemoradiotherapy

BACKGROUND: Recent studies have indicated that the systemic inflammation response index (SIRI) can efficiently predict survival outcomes in various tumor types. Thusly, in absence of comparable investigations in limited-stage small-cell lung cancers (LS-SCLCs), we aimed to retrospectively evaluate t...

Descripción completa

Detalles Bibliográficos
Autores principales: Kucuk, Ahmet, Ozkan, Emine Elif, Eskici Oztep, Sukran, Mertsoylu, Huseyin, Pehlivan, Berrin, Selek, Ugur, Topkan, Erkan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7759417/
https://www.ncbi.nlm.nih.gov/pubmed/33381177
http://dx.doi.org/10.1155/2020/8832145

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7759417/
https://www.ncbi.nlm.nih.gov/pubmed/33381177
http://dx.doi.org/10.1155/2020/8832145

Ejemplares similares